Given the distinct global DNA methylation and gene expression profile, we advocate for KAT6B/A::KANSL1 uterine tumours to be recognized as a distinct type of uterine sarcoma—KAT6B/A::KANSL1 uterine sarcomas. This evidence concerns the gene KANSL1 and uterine corpus sarcoma.